Chief Accounting Officer · BioStem Technologies, Inc. · Common Stock
Side
M
Value
—
Shares
970
Price
—
Executed
Aug 9, 2026
Disclosed
Aug 20, 2026
Disclosure timeline11 days from execution to publication · legal deadline 2 business days
Aug 9 executedAug 20, 2026 disclosed
BSEM · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · 1.5% of prior position
Filing timing+10 / 15
Disclosed 9 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Fortunato Michael A filed this Form 4 reporting a option exercise of BSEM on Aug 9, 2026. It became public on Aug 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Accounting Officer
Fortunato Michael Acik:0002147232
Issuer
BioStem Technologies, Inc.cik:0001658678
Revision history · 0
No field has changed since this record was first ingested.
